Tvardi Therapeutics Inc.

TVRD | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.72

+$0.11 (+6.83%)

Sep 22, 2026, 11:09 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $15.1M

Enterprise Value $-516.04K

Beta 0.39

Average Volume 2.17M

Shares Outstanding (Diluted) 9.38M

Shares Change YoY 10.95%

Institutional Ownership 28.81%

Exchange NASDAQ

ISIN US1407553072

Price Performance

Price Change 1M -14.4%

Price Change 3M -33.5%

Price Change 6M -51.1%

Price Change YTD -60.5%

Price Change 1Y -95.7%

Price Change 3Y -89.0%

Price Change 5Y -89.0%

1M CAGR (ann.) -13.9%

1Y CAGR (ann.) -95.8%

5Y CAGR (ann.) N/A

All-Time CAGR -53.5%

Valuation

PE Ratio -0.58

Forward PE N/A

PEG Ratio 0.01

Forward PEG 0.07

PS Ratio N/A

Forward PS N/A

PB Ratio 1.80

P/FCF Ratio -0.60

P/Adj. FCF Ratio -0.58

P/OCF Ratio -0.60

EV/Sales N/A

EV/EBIT 0.02

EV/EBITDA 0.02

EV/FCF 0.02

Earnings Yield -173.3%

FCF Yield -165.7%

Adj. FCF Yield -172.7%

Financial Health

Net Cash $15.77M

Total Debt $145K

Cash & Short-Term Investments $15.77M

Total Assets $17.52M

Current Ratio 1.87

Quick Ratio 1.87

Debt / Equity Ratio 0.02

Debt / EBITDA -0.01

Debt / FCF -0.01

OCF / Debt -172.61

Interest Coverage 0.00

Altman Z-Score -13.29

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -4.2%

Returns

Return on Assets -148.8%

Return on Equity -145.4%

Return on Invested Capital -319.1%

Return on Capital Employed -323.7%

Return on Tangible Assets -151.3%

Historical Growth (CAGR)

Revenue CAGR 3Y -111.9%

Revenue CAGR 5Y -43.4%

Revenue CAGR 10Y N/A

EPS CAGR 3Y -4.1%

EPS CAGR 5Y 32.0%

EPS CAGR 10Y N/A

FCF CAGR 3Y 59.2%

FCF CAGR 5Y 5.7%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 4

EPS Growth Next 3Y -4.5%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.55

EPS Growth Est (next Q) -7.6%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $8.75

Price Target Upside 443.5%

Cash Flow

Operating Cash Flow $-25.03M

Free Cash Flow $-25.03M

Adj. Free Cash Flow $-26.09M

FCF Per Share -$2.67

OCF Per Share -$2.67

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-27.21M

EBITDA $-26.16M

Net Income $-26.06M

EPS (Diluted) -$2.79

Revenue / Employee N/A

Profit / Employee $-2.17M

Employees 12